Zimbabwe Health News API

{
    "totalArticles": 1537,
    "articles": [
        {
            "id": "7d214e76ad43958941fc06c78adf578c",
            "title": "A major HIV breakthrough is being tested in Cape Town | Here’s why it matters",
            "description": "In a monumental stride towards combating one of the continent’s most pressing health crises, South Africa has launched the BRILLIANT 011...",
            "content": "In a monumental stride towards combating one of the continent’s most pressing health crises, South Africa has launched the BRILLIANT 011 first-in-human clinical trial at the Desmond Tutu HIV Foundation (DTHF) site at Groote Schuur Hospital.\nWith the ... [2899 chars]",
            "url": "http://www.businessghana.com/site/news/general/343376/A-major-HIV-breakthrough-is-being-tested-in-Cape-Town-%7C-Here%E2%80%99s-why-it-matters",
            "image": "http://www.businessghana.com/site/img/../../cms/img/news/2026-02-13-160941002.jpg",
            "publishedAt": "2026-02-14T04:31:50Z",
            "lang": "en",
            "source": {
                "id": "7f556db23252cd30df2784840f07b6ab",
                "name": "BusinessGhana",
                "url": "http://www.businessghana.com"
            }
        },
        {
            "id": "b3aaec4b94e22393bdb494c07c045ed8",
            "title": "Why Fitness Bros Are Buzzing About the New Weight-Loss Peptide Retatrutide",
            "description": "“It’s definitely the most effective means ever created through science to reduce the storage of fat,” one expert told GQ.",
            "content": "The longevity bros might be fighting, but that’s not stopping the internet’s early adopters from hyping up the next big thing. Last week, podcast host Andrew Huberman highlighted Ratatrutide, a powerful new weight loss drug, posting, “retatrutide is ... [8268 chars]",
            "url": "https://www.gq.com/story/what-is-retatrutide-peptide",
            "image": "https://media.gq.com/photos/698e3beb3830b30482324e43/16:9/w_1280,c_limit/GQ26_Retatrutide.jpg",
            "publishedAt": "2026-02-13T18:31:29Z",
            "lang": "en",
            "source": {
                "id": "2a57fbb84313e5d738d9e6e317634114",
                "name": "GQ",
                "url": "https://www.gq.com"
            }
        },
        {
            "id": "2fd5db7b3a8962dcac88d7038f584dcd",
            "title": "Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau",
            "description": "WHO is aware of the proposed randomized controlled trial (RCT) on the hepatitis B birth dose vaccine in Guinea-Bissau. Based on questions raised in publicly available information and consultation with relevant experts, WHO has significant concerns regarding the study’s scientific justification, ethical safeguards, and overall alignment with established principles for research involving human participants.",
            "content": "The World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is an effective, and essential public health intervention, with a proven record. It prevents life‑threatening liver disease by stopping mother‑to‑child transmissi... [4426 chars]",
            "url": "https://www.who.int/news/item/13-02-2026-statement-on-the-planned-hepatitis-b-birth-dose-vaccine-trial-in-guinea-bissau",
            "image": "https://cdn.who.int/media/images/default-source/headquarters/teams/external-relations-governance-(ext)/department-of-communications-(dco)/digital-social-visual-(dsv)/who-logo-at-headquarters.tmb-1200v.jpg?sfvrsn=34ba81d2_6",
            "publishedAt": "2026-02-13T18:30:53Z",
            "lang": "en",
            "source": {
                "id": "d00521712c77237b0d814b53cd7d67b0",
                "name": "World Health Organization (WHO)",
                "url": "https://www.who.int"
            }
        }
    ]
}